Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Cancers|February 15, 2022
External Validation of the RETREAT Score for Prediction of Hepatocellular Carcinoma Recurrence after Liver TransplantationMaria C van Hooff, Milan J Sonneveld, Jan N Ijzermans, et al.
Translational Oncology|April 29, 2021
Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinomaZhouhong Ge, Jean C A Helmijr, Maurice P H M Jansen, et al.
Journal of Hepatology|March 7, 2006
Analysis of intrahepatic HBV-specific cytotoxic T-cells during and after acute HBV infection in humansDave Sprengers, Renate G van der Molen, Johannes G Kusters, et al.
Clinics and Research in Hepatology and Gastroenterology|October 28, 2020
HLA matching and rabbit antithymocyte globulin as induction therapy to avoid multiple forms of rejection after a third liver transplantationAafke A Duizendstra, Michail Doukas, Michiel G H Betjes, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 30, 2026
Selective internal radiotherapy vs transarterial chemoembolization for unresectable hepatocellular carcinoma: a systematic reviewPam E van der Meeren, Sverre Beijer, Merve Rousian, et al.
Antiviral Therapy|November 21, 2007
Induction of regulatory T-cells and interleukin-10-producing cells in non-responders to pegylated interferon-alpha therapy for chronic hepatitis BDave Sprengers, Jeroen N Stoop, Rekha S Binda, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 23, 2016
IFN regulatory factor 1 restricts hepatitis E virus replication by activating STAT1 to induce antiviral IFN-stimulated genesLei Xu, Xinying Zhou, Wenshi Wang, et al.
Hepatology (Baltimore, Md.)|September 7, 2004
Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis BRenate G van der Molen, Dave Sprengers, Rekha S Binda, et al.
European Journal of Gastroenterology & Hepatology|May 20, 2016
Hepatocellular carcinoma in noncirrhotic livers is associated with steatosis rather than steatohepatitis: potential implications for pathogenesisSuzanne van Meer, Karel J van Erpecum, Dave Sprengers, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 16, 2021
Histopathological growth patterns modify the prognostic impact of microvascular invasion in non-cirrhotic hepatocellular carcinomaYannick M Meyer, Berend R Beumer, Diederik J Höppener, et al.
Pageof 9